Hester Biosciences
1,713.70
-9.70(-0.56%)
Market Cap₹1,466.10 Cr
PE Ratio37.68
IndustryHealthcare
Company Performance:
1D-0.56%
1M-16.48%
6M-3.45%
1Y-26.45%
5Y-3.05%
View Company Insightsright
Latest news about Hester Biosciences
Hester Biosciences Reports Mixed Q1 Results with Strong Africa Turnaround Despite India Business Headwinds Aug 04, 2025
Hester Biosciences reported mixed Q1 results. Standalone revenue declined 14% to INR 63.00 crores, with PAT down 7%, due to delayed government immunization programs. Animal Health division saw a 33% decline, while Poultry Healthcare grew 2%. Consolidated PAT grew over 100%, driven by international performance. Hester Africa achieved a significant turnaround, posting INR 5.00 crores profit on INR 17.00 crores revenue. Management remains optimistic about future growth, expecting institutional demand to normalize and awaiting regulatory clearances for new vaccine launches.
Hester Biosciences Reports Mixed Q1 Results: Consolidated Profit Surges 131% Despite Standalone Decline Aug 01, 2025
Hester Biosciences Declares Dividend Amidst Q4 Profit Decline May 09, 2025